&w=3840&q=100)
Market regulator Sebi nudges mutual funds to push bite-sized SIPs
Khushboo Tiwari Mumbai
Listen to This Article
The Securities and Exchange Board of India (Sebi) is encouraging fund houses, through their industry association, to accelerate the launch of micro systematic investment plans (SIPs), as over two-thirds of the mutual fund (MF) industry have yet to introduce them.
According to sources, following a nudge from Sebi, the Association of Mutual Funds in India (Amfi) wrote to fund houses on June 27, seeking information on their plans to offer the ₹250 SIPs. Announced in February, the so-called Chhoti SIP initiative is aimed at enhancing the financialisation of savings.
In a consultation paper in January, the regulator proposed cost subsidies
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
2 hours ago
- Mint
Safex Chemicals IPO: Speciality chemicals firm files DRHP with SEBI for ₹450 crore IPO
Safex Chemicals is in the process of bringing its initial public offering (IPO) of ₹ 450 crore in the near future. The speciality chemicals company has filed a Draft Red Herring Prospectus (DRHP) with the capital markets regulator, Securities and Exchange Board of India (SEBI), to bring the issue, which combines a fresh issue of ₹ 450 crore and an offer for sale (OFS) up to 3,57,34,818 shares. The offer also includes a subscription reservation by eligible employees in the employee reservation portion. The offer is being made through the book-building process, wherein not more than 50 per cent of the offer is allocated to qualified institutional buyers, and not less than 15 per cent and 35 per cent of the offer is assigned to non-institutional and retail individual bidders, respectively. According to the company, the proceeds from the fresh issue to the extent of ₹ 255.59 crore will be used for the repayment or prepayment of certain or all of the borrowings availed by it. Besides, about ₹ 110 crore of the proceeds will be used to repay or prepay certain or all of the borrowings taken out by its subsidiary, Shogun Organics. Some parts of the net proceeds will be used for general corporate purposes. Axis Capital Limited, JM Financial Limited and SBI Capital Markets Limited are the book-running lead managers of the issue, while KFin Technologies is the registrar to the offer. Incorporated in 1991, Safex Chemicals is a specialty chemicals company with a focus on agrochemicals. It operates in branded formulation, speciality chemicals and contract development and manufacturing (CDM') verticals, catering to the needs of farmers and global agrochemical companies. For the financial year 2022-23 (FY23), the company's revenue from operations stood at ₹ 1,161.02 crore, which rose to ₹ 1,404.59 crore in FY24 and ₹ 1,584.78 crore in FY25. However, the company has been incurring losses in the last three financial years. In FY23, it suffered a loss of ₹ 1.02 crore, in FY24 ₹ 22.79 crore and in FY25 ₹ 14.29 crore. EBITDA for FY23, FY24 and FY25 stood at ₹ 149.06 crore, ₹ 118.65 crore and ₹ 233.03 crore, respectively. EBITDA margin for FY23, FY24 and FY25 stood at 12.84 per cent, 8.45 per cent and 14.70 per cent, respectively. Read all IPO-related news here Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
Mint
2 hours ago
- Mint
Safex Chemicals IPO: Speciality chemicals firm files DRHP with SEBI for ₹450 crore IPO
Safex Chemicals is in the process of bringing its initial public offering (IPO) of ₹ 450 crore in the near future. The speciality chemicals company has filed a Draft Red Herring Prospectus (DRHP) with the capital markets regulator, Securities and Exchange Board of India (SEBI), to bring the issue, which combines a fresh issue of ₹ 450 crore and an offer for sale (OFS) up to 3,57,34,818 shares. The offer also includes a subscription reservation by eligible employees in the employee reservation portion. The offer is being made through the book-building process, wherein not more than 50 per cent of the offer is allocated to qualified institutional buyers, and not less than 15 per cent and 35 per cent of the offer is assigned to non-institutional and retail individual bidders, respectively. According to the company, the proceeds from the fresh issue to the extent of ₹ 255.59 crore will be used for the repayment or prepayment of certain or all of the borrowings availed by it. Besides, about ₹ 110 crore of the proceeds will be used to repay or prepay certain or all of the borrowings taken out by its subsidiary, Shogun Organics. Some parts of the net proceeds will be used for general corporate purposes. Axis Capital Limited, JM Financial Limited and SBI Capital Markets Limited are the book-running lead managers of the issue, while KFin Technologies is the registrar to the offer. Incorporated in 1991, Safex Chemicals is a specialty chemicals company with a focus on agrochemicals. It operates in branded formulation, speciality chemicals and contract development and manufacturing (CDM') verticals, catering to the needs of farmers and global agrochemical companies. For the financial year 2022-23 (FY23), the company's revenue from operations stood at ₹ 1,161.02 crore, which rose to ₹ 1,404.59 crore in FY24 and ₹ 1,584.78 crore in FY25. However, the company has been incurring losses in the last three financial years. In FY23, it suffered a loss of ₹ 1.02 crore, in FY24 ₹ 22.79 crore and in FY25 ₹ 14.29 crore. EBITDA for FY23, FY24 and FY25 stood at ₹ 149.06 crore, ₹ 118.65 crore and ₹ 233.03 crore, respectively. EBITDA margin for FY23, FY24 and FY25 stood at 12.84 per cent, 8.45 per cent and 14.70 per cent, respectively. Read all IPO-related news here
Economic Times
2 hours ago
- Economic Times
Capital market stocks: Some corrections are opportunities, 5 stocks with potential downside to upside from -20% to +24%
On Friday, all capital market-related stocks witnessed a correction. The reason heard on the street: A SEBI order banning one entity from dealing in the Indian market would impact volumes in the F&O segment and, hence, income. The other reason, there could be some deepening of the probe and that might impact sentiment. Now, there cannot be a more absurd reason given for the decline in capital market-related stocks. How can a clean-up by the FONT SIZE SAVE PRINT COMMENT
